µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º sKIWr{D
aNb=gjLpt
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Mt)~:V+:
#(3w6l2
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) rb%P30qc4
X>OO4SV
1. ICAM-1 dA>t
!q~s-~d^
2. interleukin 12(IL-12) =]E(iR_&
g[Ah>
5
3. tumor infiltrating lymphocyte %@q52ZQ
aWek<Y~+
4. TCR/CD3 complex yCkfAx8]
!> b>"\b
5. hematopoietin receptor family QU16X
le yhiL<
6. individual idiotype(IdI) }MY7<sMDOy
z=<T[Uy
7. integrin CyO2Z
3;~1rw=$<
8. colony-stimulatory factor (CSF) `x$d8(1J`#
X!&DKE
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© !y$Hr[v
q,VJpqQ
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )?
Tn2Z{.q$
q7mqzMDk
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ /A}3kTp
OGg9e
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ^DXERt&3
7!w@u6Q
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ {,.1KtrSN
fL
ng[&
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) 85$MHod}[,
#rMMOu9r2
1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ :Gqyj_|<
>T;"bcb
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) ['R2$z
>WE3$Q>bi
3. immunoglobulin superfamily (IgSF) G%
S=K2v
LdI)
4. selectin w_@NT}
4Cke(G
5. anti-idiotypic antibody (¦ÁId) 'Kxs>/y3
}|H]>U&
6. major histocompatibility complex(MHC) v3[Z]+ ]
M |?qSFv:
7. immunotolerance 8U0y86q>)E
d~C
YZ
8. biological reponse modifier(BRM) gSEj/?
f"xi7vJv!f
9. immune reponse gene (Ir gene) YKf,vHau
C>$5<bx
10. reshaped antibody (or reconstituted antibody) _ot4HmD
LT!B]y
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© v~q2D"
;nji<
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ -Vn9YeH+
g
Z
2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? @Rj&9/\L
dl'pl
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ vi
4
u `
!Y!Cv %
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? ylLQKdcL
'I($IM
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ uaNJTob
+ Q
If7=
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? l?NRQTG
/
S$p_7N
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 699z@>$}
= PcmJG]
¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ rhMsZ={M
Ym(^
ih
1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨?
g[@K
d
4wX{ N
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ XPd>DH(Yc
eU1= :n&&\
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ~7Kqc\/H&I
=#&K\
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: &}nU#)IX
}.3F|H
̉񧄤 '(5 &Sj/C
A5!j
rSyv
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© HDIB GG~
[VT&
1. CD8 im>Sxu@
J|sX
{/WT
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) XrYMv
WT
M
E[Wg\
3. immunoglobulin fold(Ig fold) ZO2u[HSO>
v!E0/
gD
4. cadherin (Ca-dependent cell adhesion moleculers) @b=tjQO_
(?J6vK}S
5. idiotype-anti-idiotypic antibody immune network theory x1Q}B
K
$\az%NE
6. HLA class II antigen :4}?%3&;
?1x
BhKq
7. complementarity-determining region (CDR) F@kOj*5,[
o{4ya jt
8. perforin(or pore-forming protein ,PFP) ,ZJI]Q=!
)F0_V
4
9. high affinity IL-2 receptor @z EEX9U
z_*]joL
10. artificial active immunization g:q+.6va"
RsIEY5Q
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© q =b.!AZy
;wbQTp2
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ&jl'1mZ
HPCzh
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 oB-&ma[ZS
Xl#vVyO
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ %/oOM\}++
Fla[YWS
4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ N;F1Z-9
+%>s\W+?]
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ &{7n
=3{h9
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? Y`LZ/Tgk
%+w>`k3(N
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ?f1%)]>
j^1T3 +
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ ;} gvBI2e
'P)xY-15
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ @?aNvWeavH
8!TbJVR
ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ #v:<\-MjN
29Kuq ;6
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 4.,e3
1UJ(._0hR
1. immunoglobulin gene rearrangement (
]AErz+
O!d^v9hM,
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) tW|B\p}
~`#.ZMO
3. flow cytometry(FCM) eoR@5OA&
(*/P~$xIj
4. carrier effect 9$~D4T
1;fs`k0p
5. positive selection of T lymphocytes in thymus 5WO!u:!'
_(
w4 \]
6. mouse TH1(Th1) and TH2(Th2) subsets ZZ!d:1'7
9=rYzA?)+
7. perforin (pore-forming protein ,PFP) F
`
J(+
E-*udQ
8. ADCC(antibody-dependent cell-mediated cytotoxicity) b= F"
`*KS`
z?
9. SH-2(src-homology region 2) bLCr h(<
*X*D,
VY
10. Ab2¦Â (internal image) To}L%)
PgB=<#9
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© MG8-1M
@`%.\_
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? }=?r`J+Ev;
HZ[&ZNTa
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? @*is]d+Ya
QdUl-(
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠt^8#
~o!%
~>>o'H6
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ g|)e3q{M
Qyt6+xL
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠu+(e,
t
at7/KuY!~
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) bTO$B2eh|
fkRb;aIl
ÃâÒßѧרҵ£º &bBp`h
-d_FB?X
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ eC[g"Ef
1 68
U-<
2. ÊԱȽÏÈËT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? oJ6
d:
"Hgn2o.;5
´«È¾²¡Ñ§×¨Òµ£º Bfi9%:eG
~+CNED0z+
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦ÄÜ¿É·¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ -7=pb#y
+Tq
_n@
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØϵ¡£ #Sn&Wo
^$?8!
WE
Ïû»¯×¨Òµ£º QXXc
Jc~
FAPgXmFzx
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ >x!N[N
@G
61jDI^:
2.¼òÊöճĤÏà¹ØÁÜ°ÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌص㡣·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? m#8}!u&
Bm~>w`1wK
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ >!bYuVHA
/Zm@.%.
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© YRC`2)_'
3P#1fI(c
1. Fas(CD95)/FasL Dtr'X@U
ve
K
2. common chain of cytokine receptor *}mtVa_|
@XmMD6{<